Synopsys, Inc. $SNPS Position Increased by Diversified Trust Co

Diversified Trust Co grew its position in Synopsys, Inc. (NASDAQ:SNPS) by 30.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,653 shares of the semiconductor company’s stock after buying an additional 1,329 shares during the quarter. Diversified Trust Co’s holdings in Synopsys were worth $2,241,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the company. Sankala Group LLC acquired a new position in Synopsys in the 4th quarter worth approximately $25,000. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Synopsys during the 4th quarter valued at $28,000. Caitong International Asset Management Co. Ltd acquired a new stake in Synopsys during the 4th quarter valued at $28,000. Atlas Capital Advisors Inc. purchased a new stake in shares of Synopsys in the fourth quarter valued at $32,000. Finally, Osbon Capital Management LLC purchased a new stake in shares of Synopsys in the fourth quarter valued at $34,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Stock Performance

Shares of NASDAQ:SNPS opened at $455.51 on Monday. The firm has a fifty day moving average of $479.14 and a two-hundred day moving average of $462.21. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 12-month low of $376.18 and a 12-month high of $651.73. The firm has a market capitalization of $87.22 billion, a P/E ratio of 105.44, a price-to-earnings-growth ratio of 2.68 and a beta of 1.22.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The business had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same period in the prior year, the business posted $3.67 earnings per share. Synopsys’s revenue for the quarter was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities analysts expect that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

SNPS has been the subject of several recent analyst reports. Citigroup raised their target price on Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Wells Fargo & Company increased their price objective on Synopsys from $505.00 to $535.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 28th. Morgan Stanley raised their price objective on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 28th. Needham & Company LLC reaffirmed a “buy” rating and set a $580.00 target price on shares of Synopsys in a research note on Thursday, May 28th. Finally, Bank of America upped their target price on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Nine equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $563.81.

Insider Activity

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 0.56% of the company’s stock.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.